Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / SBTX - Silverback Therapeutics GAAP EPS of -$0.70 misses by $0.03

SBTX - Silverback Therapeutics GAAP EPS of -$0.70 misses by $0.03

Silverback Therapeutics Inc.
Silverback Therapeutics press release (NASDAQ:SBTX): Q1 GAAP EPS of -$0.70 misses by $0.03. CEO comment: “We believe that activating the immune response is an important component of a functional cure and may be combined with treatments that target the HBV life cycle to improve durability. Our team is on track to complete a regulatory submission in the fourth quarter of 2022, enabling the planned initiation of the single ascending dose healthy volunteer cohort of the Phase 1 study in the first quarter of 2023. We plan to report data from this cohort in the second half of 2023.”

For further details see:

Silverback Therapeutics GAAP EPS of -$0.70 misses by $0.03
Stock Information
Company Name: Silverback Therapeutics Inc.
Stock Symbol: SBTX
Market: NASDAQ
Menu
SBTX SBTX Quote SBTX Short SBTX News SBTX Articles SBTX Message Board
Get SBTX Alerts

News, Short Squeeze, Breakout and More Instantly...